OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
May 02, 2021
Updates to user fee programs that fund FDA operations are being finalized by industry stakeholders for approval by Congress.
March 08, 2021
USP is collaborating with Phlow to build a new lab that will develop test methods and standards to facilitate broader adoption of continuous manufacturing.
February 03, 2021
Advanced manufacturing technologies are available, but challenges need to be addressed.
October 30, 2020
The Center for Drug Evaluation and Research is studying factors that influence the development of generic versions of brand-name drugs.
June 02, 2020
FDA and the US Congress support innovation and access to cheaper medicines.
May 19, 2020
HHS announces $354 million in funding for private industry to manufacture generic drugs in the US from raw materials to finished product.
May 02, 2020
Discovery of carcinogenic nitrosamines in three of the world’s most widely prescribed drugs is driving efforts to better detect, control and prevent their generation in APIs and finished drug products.
April 06, 2020
A quick look at the history of OTC dosage form development shows the importance of patient-centered innovation.
April 01, 2020
With new tests showing NDMA levels increase under normal storage conditions, FDA calls for removal of ranitidine products from the market.
February 27, 2020
Perrigo will be producing a limited amount of the generic inhaler medication but will accelerate production to meet future demands in collaboration with Catalent.